+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cerebral Palsy"

From
Neurorehabilitation Devices Market - Global Forecast 2026-2032 - Product Thumbnail Image

Neurorehabilitation Devices Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 184 Pages
  • Global
From
From
Neurorehabilitation Devices Market Report 2026 - Product Thumbnail Image

Neurorehabilitation Devices Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
Neurorehabilitation Devices Market - Forecast from 2026 to 2031 - Product Thumbnail Image

Neurorehabilitation Devices Market - Forecast from 2026 to 2031

  • Report
  • January 2026
  • 150 Pages
  • Global
From
Neurorehabilitation Market - Forecast from 2026 to 2031 - Product Thumbnail Image

Neurorehabilitation Market - Forecast from 2026 to 2031

  • Report
  • January 2026
  • 151 Pages
  • Global
From
From
Neurorehabilitation Devices Patent Landscape Report - Product Thumbnail Image

Neurorehabilitation Devices Patent Landscape Report

  • Report
  • August 2024
  • 200 Pages
  • Global
From
Loading Indicator

Cerebral Palsy (CP) is a neurological disorder that affects movement, posture, and coordination. It is caused by damage to the developing brain, usually before or during birth. CP is a lifelong condition that can range from mild to severe, and can affect physical, cognitive, and social functioning. The therapeutic area for CP is focused on improving the quality of life for those affected. Treatment options include physical, occupational, and speech therapy, as well as medications, assistive devices, and surgery. There is also a focus on providing support and education to families and caregivers. Companies in the CP market include AbbVie, Biogen, GlaxoSmithKline, Novartis, Pfizer, and Sanofi. These companies are involved in the development of medications, therapies, and assistive devices to help those with CP. Show Less Read more